Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.540

-1.3%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kevin Podsiadlik who wrote (6610)	2/9/2000 10:34:00 AM
From: DanZ	Read Replies (2) of 10293

Kevin, Gum Tech's press release said: "The demand for Zicam(TM) during the quarter was tremendous after our formal launch on November 1, 1999. Two months after the launch, according to sales data, Zicam(TM) was in the top 2% of the cough and cold category." I apologize if "cold remedies" has a different connotation than "cough and cold category". The cough and cold category certainly includes products such as Dristan, Robitussin, and Nyquil.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next